Response to low-dose intravenous immunoglobulin in a case of recalcitrant Darier disease
暂无分享,去创建一个
[1] F. Ali,et al. Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes , 2018, Clinical and experimental dermatology.
[2] K. Cordoro,et al. Netherton Syndrome Mimicking Pustular Psoriasis: Clinical Implications and Response to Intravenous Immunoglobulin , 2016, Pediatric dermatology.
[3] Y. Tüzün,et al. Darier disease: A fold (intertriginous) dermatosis. , 2015, Clinics in dermatology.
[4] M. Simon,et al. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. , 2013, The Journal of allergy and clinical immunology.
[5] A. Hovnanian. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition , 2013, Cell and Tissue Research.
[6] T. Mauro,et al. SERCA2-controlled Ca2+-dependent Keratinocyte Adhesion and Differentiation is Mediated via the Sphingolipid Pathway- a Novel Therapeutic Target for Darier’s Disease , 2011, The Journal of investigative dermatology.
[7] J. Orange,et al. Comèl-Netherton syndrome defined as primary immunodeficiency. , 2009, The Journal of allergy and clinical immunology.